TSE:TRL - Trilogy International Partners Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$4.24 +0.07 (+1.68 %)
(As of 07/19/2018 03:16 PM ET)
Previous CloseC$4.17
Today's RangeC$4.19 - C$4.25
52-Week RangeC$4.09 - C$8.52
Volume3,900 shs
Average Volume31,664 shs
Market CapitalizationC$305.41 million
P/E RatioN/A
Dividend Yield0.48%
BetaN/A
Trilogy International Partners logoTrilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services to customers and international visitors roaming on its networks in the United States, Bolivia, and New Zealand. Its wireless voice and data communications services include local, international long distance, and roaming services. The Company also provides fixed broadband communications services to business and residential customers. It serves approximately 15.4 million customers. The company is headquartered in Bellevue, Washington.

Receive TRL News and Ratings via Email

Sign-up to receive the latest news and ratings for TRL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange TSE
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolTSE:TRL
CUSIPN/A
Phone+1-425-4585900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-2.92%
Return on EquityN/A
Return on Assets-2.98%

Miscellaneous

EmployeesN/A
Outstanding Shares55,276,000
Market CapC$305.41

The Truth About Cryptocurrencies

Trilogy International Partners (TSE:TRL) Frequently Asked Questions

What is Trilogy International Partners' stock symbol?

Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."

How often does Trilogy International Partners pay dividends? What is the dividend yield for Trilogy International Partners?

Trilogy International Partners announced a quarterly dividend on Friday, April 13th. Investors of record on Friday, May 4th will be paid a dividend of 0.02 per share on Friday, May 4th. This represents a $0.08 annualized dividend and a dividend yield of 1.89%. The ex-dividend date of this dividend is Friday, April 13th. View Trilogy International Partners' Dividend History.

What price target have analysts set for TRL?

3 analysts have issued twelve-month target prices for Trilogy International Partners' shares. Their predictions range from C$5.50 to C$8.00. On average, they anticipate Trilogy International Partners' stock price to reach C$7.17 in the next twelve months. This suggests a possible upside of 69.0% from the stock's current price. View Analyst Ratings for Trilogy International Partners.

What is the consensus analysts' recommendation for Trilogy International Partners?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Trilogy International Partners' key competitors?

Who are Trilogy International Partners' key executives?

Trilogy International Partners' management team includes the folowing people:
  • Mr. John William Stanton, Co-Founder & Chairman (Age 63)
  • Mr. Bradley Jay Horwitz, Pres, CEO & Non-Independent Director (Age 62)
  • Ms. Theresa E. Gillespie, Co-Founder & Non-Independent Director (Age 65)
  • Mr. Erik Mickels, Sr. VP & CFO
  • Ms. Ann Saxton, VP, Investor Relations & Corp. Devel.

Has Trilogy International Partners been receiving favorable news coverage?

Media stories about TRL stock have been trending somewhat positive on Thursday, according to Accern Sentiment. Accern ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Trilogy International Partners earned a media sentiment score of 0.02 on Accern's scale. They also gave headlines about the specialty pharmaceutical company an impact score of 45.16 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Trilogy International Partners?

Shares of TRL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Trilogy International Partners' stock price today?

One share of TRL stock can currently be purchased for approximately C$4.24.

How big of a company is Trilogy International Partners?

Trilogy International Partners has a market capitalization of C$305.41 million.

How can I contact Trilogy International Partners?

Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.


MarketBeat Community Rating for Trilogy International Partners (TSE TRL)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  139 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  222
MarketBeat's community ratings are surveys of what our community members think about Trilogy International Partners and other stocks. Vote "Outperform" if you believe TRL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.